Regeneron Pharmaceuticals Q1 Earnings Call Highlights [Yahoo! Finance]
Regeneron Pharmaceuticals, Inc. (REGN)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.regeneron.com
Company Research
Source: Yahoo! Finance
Regeneron Pharmaceuticals (NASDAQ:REGN) reported what management described as a strong start to 2026, driven by growth in key commercial products, continued pipeline progress, and an updated capital return plan. On the company's first-quarter earnings call, executives also addressed regulatory timing for EYLEA HD's prefilled syringe, highlighted clinical and regulatory milestones across multiple programs, and discussed a newly announced Most-Favored-Nation pricing agreement with the U.S. government. First-quarter performance and key product trends Board Co-Chair, Co-Founder, President, and CEO Dr. Leonard Schleifer said Regeneron delivered “double-digit growth across both revenues and earnings,” with total revenues up 19% versus the first quarter of 2025 and non-GAAP earnings per share up 15%. ? Homebuilder Earnings: D.R. Horton Sticks Out as Pulte & NVR Sales Tank Pfizer Adds to Its Big Bet on Weight Loss Drugs Commercial performance was led by Dupixent, EYLEA HD, and Libt
Show less
Read more
Impact Snapshot
Event Time:
REGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
News
- Regeneron Tops Q1 Estimates on Dupixent Momentum [Yahoo! Finance]Yahoo! Finance
- Regeneron's C5 Milestones And Autoimmune Bets Shape Future Valuation [Yahoo! Finance]Yahoo! Finance
- Regeneron (NASDAQ:REGN) Reports Strong Q1 CY2026 [Yahoo! Finance]Yahoo! Finance
- Regeneron Reports First Quarter 2026 Financial and Operating Results [Yahoo! Finance]Yahoo! Finance
- Regeneron Reports First Quarter 2026 Financial and Operating ResultsGlobeNewswire
REGN
Earnings
- 4/29/26 - Beat
REGN
Sec Filings
- 4/29/26 - Form 10-Q
- 4/29/26 - Form 8-K
- 4/24/26 - Form ARS
- REGN's page on the SEC website